Glazer Capital LLC’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Glazer Capital LLC’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28,788	Closed	-$284K	–	780
2022 Q2	$284K	Buy	28,788 +26,343	+1,077%	+$261K	0.01%	472
2022 Q1	$24K	Buy	+2,445	New	+$24.2K	﹤0.01%	479
2021 Q4	–	Sell	-132,331	Closed	-$1.3M	–	1079
2021 Q3	$1.3M	Sell	132,331 -155,002	-54%	-$1.55M	0.02%	444
2021 Q2	$2.89M	Sell	287,333 -6,501	-2%	-$65.9K	0.04%	383
2021 Q1	$2.98M	Sell	293,834 -8,783	-3%	-$93.6K	0.04%	414
2020 Q4	$3.14M	Buy	+302,617	New	+$3.16M	0.11%	185

Other funds holding FLACU

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Glazer Capital LLC's FLACU Position: Q3 2022 in Review

Glazer Capital LLC sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q3 2022, closing a stake of 28,788 shares — an estimated $284K sold.

Glazer Capital LLC first reported a position in FLACU in Q4 2020 and held it in 6 quarters. The position peaked at $3.14M in Q4 2020. 14 funds tracked by Wall St. Rank hold FLACU as of Q3 2022.

Glazer Capital LLC reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q3 2022 after selling out during the quarter.
Glazer Capital LLC sold 28,788 Frazier Lifesciences Acquisition Corporation Unit shares in Q3 2022, an estimated $284K.
Glazer Capital LLC first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 6 quarters.
Glazer Capital LLC's Frazier Lifesciences Acquisition Corporation Unit position peaked at $3.14M in Q4 2020.
14 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q3 2022.

Based on Glazer Capital LLC's 13F filing for Q3 2022, filed 14 Nov 2022.